Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.
Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...
Vaccine skeptics have said changes were introduced to "accommodate" the shortcomings of the COVID-19 vaccines.
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
Thomas Kwan, initially pleaded not guilty to attempted murder but reversed his plea after prosecutors presented their evidence.
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...
The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents ... has ...
Hong Kong will have another choice for a Covid-19 vaccine targeting the Omicron variant, with drug maker BioNTech offering to make its second-generation jabs available in the city as early as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback